New routes for allergen immunotherapy

References

• Bauchau V, Durham SR. Prevalence and rate of diagnosis of allergic rhinitis in Europe. Eur Respir J 2004; 24:758 - 64; http://dx.doi.org/10.1183/09031936.04.00013904; PMID: 15516669
   PubMed Web of Science ®Google Scholar
• Scadding GK, Durham SR, Mirakian R, Jones NS, Leech SC, Farooque S, et al, British Society for Allergy and Clinical Immunology. BSACI guidelines for the management of allergic and non-allergic rhinitis. Clin Exp Allergy 2008; 38:19 - 42; http://dx.doi.org/10.1111/j.1365-2222.2007.02888.x; PMID: 18081563
   PubMed Web of Science ®Google Scholar
• Smith H. Asthma, inflammation, eosinophils and bronchial hyperresponsiveness. Clin Exp Allergy 1992; 22:187 - 97; http://dx.doi.org/10.1111/j.1365-2222.1992.tb03072.x; PMID: 1571812
   PubMed Web of Science ®Google Scholar
• Frew AJ. Allergen immunotherapy. J Allergy Clin Immunol 2010; 125:Suppl 2 S306 - 13; http://dx.doi.org/10.1016/j.jaci.2009.10.064; PMID: 20176266
   PubMed Web of Science ®Google Scholar
• Walker SM, Durham SR, Till SJ, Roberts G, Corrigan CJ, Leech SC, et al, British Society for Allergy and Clinical Immunology. Immunotherapy for allergic rhinitis. Clin Exp Allergy 2011; 41:1177 - 200; http://dx.doi.org/10.1111/j.1365-2222.2011.03794.x; PMID: 21848757
   PubMed Web of Science ®Google Scholar
• Noon L. Prophylactic inoculations against hay fever. Lancet 1911; 177:1572 - 3; http://dx.doi.org/10.1016/S0140-6736(00)78276-6
   Google Scholar
• Freeman J. Further observations on the treatment of hay fever by hypodermic inoculations of pollen vaccine. Lancet 1911; 178:814 - 7; http://dx.doi.org/10.1016/S0140-6736(01)40417-X
   Google Scholar
• Alvarez-Cuesta E, Bousquet J, Canonica GW, Durham SR, Malling HJ, Valovirta E, EAACI, Immunotherapy Task Force. Standards for practical allergen-specific immunotherapy. Allergy 2006; 61:Suppl 82 1 - 20; http://dx.doi.org/10.1111/j.1398-9995.2006.01219_1.x; PMID: 16930249
   PubMed Web of Science ®Google Scholar
• Calderón MA, Casale TB, Togias A, Bousquet J, Durham SR, Demoly P. Allergen-specific immunotherapy for respiratory allergies: from meta-analysis to registration and beyond. J Allergy Clin Immunol 2011; 127:30 - 8; http://dx.doi.org/10.1016/j.jaci.2010.08.024; PMID: 20965551
   PubMed Web of Science ®Google Scholar
• Calderon MA, Alves B, Jacobson M, Hurwitz B, Sheikh A, Durham S. Allergen injection immunotherapy for seasonal allergic rhinitis. Cochrane Database Syst Rev 2007; CD001936; PMID: 17253469
   PubMed Web of Science ®Google Scholar
• Nelson HS. Allergen immunotherapy: where is it now?. J Allergy Clin Immunol 2007; 119:769 - 79; http://dx.doi.org/10.1016/j.jaci.2007.01.036; PMID: 17337297
   PubMed Web of Science ®Google Scholar
• von Moos S, Kündig TM, Senti G. Novel administration routes for allergen-specific immunotherapy: a review of intralymphatic and epicutaneous allergen-specific immunotherapy. [xi.] Immunol Allergy Clin North Am 2011; 31:391 - 406, xi; http://dx.doi.org/10.1016/j.iac.2011.02.012; PMID: 21530827
   PubMed Web of Science ®Google Scholar
• Senti G, Martínez Gómez JM, Rettig L, Wüthrich B, Kündig TM, Johansen P. Immunotherapeutic targeting of allergic disease. Inflamm Allergy Drug Targets 2006; 5:243 - 52; http://dx.doi.org/10.2174/187152806779010963; PMID: 17168795
   PubMedGoogle Scholar
• Kündig TM, Bachmann MF. Allergen-specific immunotherapy: regulatory T cells or allergen-specific IgG?. Hum Vaccin 2010; 6:673 - 5; http://dx.doi.org/10.4161/hv.6.8.12007; PMID: 20523122
   PubMed Web of Science ®Google Scholar
• Bal SM, Ding Z, van Riet E, Jiskoot W, Bouwstra JA. Advances in transcutaneous vaccine delivery: do all ways lead to Rome?. J Control Release 2010; 148:266 - 82; http://dx.doi.org/10.1016/j.jconrel.2010.09.018; PMID: 20869998
   PubMed Web of Science ®Google Scholar
• Nestle FO, Di Meglio P, Qin JZ, Nickoloff BJ. Skin immune sentinels in health and disease. Nat Rev Immunol 2009; 9:679 - 91; PMID: 19763149
   PubMed Web of Science ®Google Scholar
• Bos JD, Meinardi MM. The 500 Dalton rule for the skin penetration of chemical compounds and drugs. Exp Dermatol 2000; 9:165 - 9; http://dx.doi.org/10.1034/j.1600-0625.2000.009003165.x; PMID: 10839713
   PubMed Web of Science ®Google Scholar
• Babiuk S, Baca-Estrada M, Babiuk LA, Ewen C, Foldvari M. Cutaneous vaccination: the skin as an immunologically active tissue and the challenge of antigen delivery. J Control Release 2000; 66:199 - 214; http://dx.doi.org/10.1016/S0168-3659(99)00274-6; PMID: 10742580
   PubMed Web of Science ®Google Scholar
• Merad M, Ginhoux F, Collin M. Origin, homeostasis and function of Langerhans cells and other langerin-expressing dendritic cells. Nat Rev Immunol 2008; 8:935 - 47; http://dx.doi.org/10.1038/nri2455; PMID: 19029989
   PubMed Web of Science ®Google Scholar
• Streilein JW. Skin-associated lymphoid tissues (SALT): origins and functions. J Invest Dermatol 1983; 80:Suppl 12s - 6s; http://dx.doi.org/10.1111/1523-1747.ep12536743; PMID: 6602189
   PubMed Web of Science ®Google Scholar
• Kupper TS, Fuhlbrigge RC. Immune surveillance in the skin: mechanisms and clinical consequences. Nat Rev Immunol 2004; 4:211 - 22; http://dx.doi.org/10.1038/nri1310; PMID: 15039758
   PubMed Web of Science ®Google Scholar
• Kapsenberg ML. Dendritic-cell control of pathogen-driven T-cell polarization. Nat Rev Immunol 2003; 3:984 - 93; http://dx.doi.org/10.1038/nri1246; PMID: 14647480
   PubMed Web of Science ®Google Scholar
• Matzinger P. Friendly and dangerous signals: is the tissue in control?. Nat Immunol 2007; 8:11 - 3; http://dx.doi.org/10.1038/ni0107-11; PMID: 17179963
   PubMed Web of Science ®Google Scholar
• Klechevsky E, Morita R, Liu M, Cao Y, Coquery S, Thompson-Snipes L, et al. Functional specializations of human epidermal Langerhans cells and CD14+ dermal dendritic cells. Immunity 2008; 29:497 - 510; http://dx.doi.org/10.1016/j.immuni.2008.07.013; PMID: 18789730
   PubMed Web of Science ®Google Scholar
• Ueno H, Schmitt N, Klechevsky E, Pedroza-Gonzalez A, Matsui T, Zurawski G, et al. Harnessing human dendritic cell subsets for medicine. Immunol Rev 2010; 234:199 - 212; http://dx.doi.org/10.1111/j.0105-2896.2009.00884.x; PMID: 20193020
   PubMed Web of Science ®Google Scholar
• Kissenpfennig A, Henri S, Dubois B, Laplace-Builhé C, Perrin P, Romani N, et al. Dynamics and function of Langerhans cells in vivo: dermal dendritic cells colonize lymph node areas distinct from slower migrating Langerhans cells. Immunity 2005; 22:643 - 54; http://dx.doi.org/10.1016/j.immuni.2005.04.004; PMID: 15894281
   PubMed Web of Science ®Google Scholar
• Swamy M, Jamora C, Havran W, Hayday A. Epithelial decision makers: in search of the ‘epimmunome’. Nat Immunol 2010; 11:656 - 65; http://dx.doi.org/10.1038/ni.1905; PMID: 20644571
   PubMed Web of Science ®Google Scholar
• Cevikbas F, Steinhoff M. IL-33: a novel danger signal system in atopic dermatitis. J Invest Dermatol 2012; 132:1326 - 9; http://dx.doi.org/10.1038/jid.2012.66; PMID: 22499037
   PubMed Web of Science ®Google Scholar
• Gilliet M, Soumelis V, Watanabe N, Hanabuchi S, Antonenko S, de Waal-Malefyt R, et al. Human dendritic cells activated by TSLP and CD40L induce proallergic cytotoxic T cells. J Exp Med 2003; 197:1059 - 63; http://dx.doi.org/10.1084/jem.20030240; PMID: 12707303
   PubMed Web of Science ®Google Scholar
• Savinko T, Matikainen S, Saarialho-Kere U, Lehto M, Wang G, Lehtimäki S, et al. IL-33 and ST2 in atopic dermatitis: expression profiles and modulation by triggering factors. J Invest Dermatol 2012; 132:1392 - 400; http://dx.doi.org/10.1038/jid.2011.446; PMID: 22277940
   PubMed Web of Science ®Google Scholar
• Soumelis V. TSLP: from allergy to vaccine adjuvant. Eur J Immunol 2012; 42:293 - 5; http://dx.doi.org/10.1002/eji.201142337; PMID: 22266716
   PubMed Web of Science ®Google Scholar
• Soumelis V, Reche PA, Kanzler H, Yuan W, Edward G, Homey B, et al. Human epithelial cells trigger dendritic cell mediated allergic inflammation by producing TSLP. Nat Immunol 2002; 3:673 - 80; PMID: 12055625
   PubMed Web of Science ®Google Scholar
• Mitragotri S. Immunization without needles. Nat Rev Immunol 2005; 5:905 - 16; http://dx.doi.org/10.1038/nri1728; PMID: 16239901
   PubMed Web of Science ®Google Scholar
• Frech SA, Dupont HL, Bourgeois AL, McKenzie R, Belkind-Gerson J, Figueroa JF, et al. Use of a patch containing heat-labile toxin from Escherichia coli against travellers’ diarrhoea: a phase II, randomised, double-blind, placebo-controlled field trial. Lancet 2008; 371:2019 - 25; http://dx.doi.org/10.1016/S0140-6736(08)60839-9; PMID: 18554712
   PubMed Web of Science ®Google Scholar
• Frerichs DM, Ellingsworth LR, Frech SA, Flyer DC, Villar CP, Yu J, et al. Controlled, single-step, stratum corneum disruption as a pretreatment for immunization via a patch. Vaccine 2008; 26:2782 - 7; http://dx.doi.org/10.1016/j.vaccine.2008.02.070; PMID: 18455283
   PubMed Web of Science ®Google Scholar
• Sullivan SP, Koutsonanos DG, Del Pilar Martin M, Lee JW, Zarnitsyn V, Choi SO, et al. Dissolving polymer microneedle patches for influenza vaccination. Nat Med 2010; 16:915 - 20; http://dx.doi.org/10.1038/nm.2182; PMID: 20639891
   PubMed Web of Science ®Google Scholar
• Enfield J, O’Connell ML, Lawlor K, Jonathan E, O’Mahony C, Leahy M. In-vivo dynamic characterization of microneedle skin penetration using optical coherence tomography. J Biomed Opt 2010; 15:046001; http://dx.doi.org/10.1117/1.3463002; PMID: 20799803
   PubMed Web of Science ®Google Scholar
• Fernando GJ, Chen X, Prow TW, Crichton ML, Fairmaid EJ, Roberts MS, et al. Potent immunity to low doses of influenza vaccine by probabilistic guided micro-targeted skin delivery in a mouse model. PLoS ONE 2010; 5:e10266; http://dx.doi.org/10.1371/journal.pone.0010266; PMID: 20422002
   PubMed Web of Science ®Google Scholar
• Haq MI, Smith E, John DN, Kalavala M, Edwards C, Anstey A, et al. Clinical administration of microneedles: skin puncture, pain and sensation. Biomed Microdevices 2009; 11:35 - 47; http://dx.doi.org/10.1007/s10544-008-9208-1; PMID: 18663579
   PubMed Web of Science ®Google Scholar
• Kim YC, Jarrahian C, Zehrung D, Mitragotri S, Prausnitz MR. Delivery systems for intradermal vaccination. Curr Top Microbiol Immunol 2012; 351:77 - 112; http://dx.doi.org/10.1007/82_2011_123; PMID: 21472533
   PubMed Web of Science ®Google Scholar
• van der Maaden K, Jiskoot W, Bouwstra J. Microneedle technologies for (trans)dermal drug and vaccine delivery. J Control Release 2012; 161:645 - 55; http://dx.doi.org/10.1016/j.jconrel.2012.01.042; PMID: 22342643
   PubMed Web of Science ®Google Scholar
• Vrdoljak A, McGrath MG, Carey JB, Draper SJ, Hill AV, O’Mahony C, et al. Coated microneedle arrays for transcutaneous delivery of live virus vaccines. J Control Release 2012; 159:34 - 42; http://dx.doi.org/10.1016/j.jconrel.2011.12.026; PMID: 22245683
   PubMed Web of Science ®Google Scholar
• Wood LC, Jackson SM, Elias PM, Grunfeld C, Feingold KR. Cutaneous barrier perturbation stimulates cytokine production in the epidermis of mice. J Clin Invest 1992; 90:482 - 7; http://dx.doi.org/10.1172/JCI115884; PMID: 1644919
   PubMed Web of Science ®Google Scholar
• Tan G, Xu P, Lawson LB, He J, Freytag LC, Clements JD, et al. Hydration effects on skin microstructure as probed by high-resolution cryo-scanning electron microscopy and mechanistic implications to enhanced transcutaneous delivery of biomacromolecules. J Pharm Sci 2010; 99:730 - 40; PMID: 19582754
   PubMed Web of Science ®Google Scholar
• Dupont C, Kalach N, Soulaines P, Legoué-Morillon S, Piloquet H, Benhamou PH. Cow’s milk epicutaneous immunotherapy in children: a pilot trial of safety, acceptability, and impact on allergic reactivity. J Allergy Clin Immunol 2010; 125:1165 - 7; http://dx.doi.org/10.1016/j.jaci.2010.02.029; PMID: 20451043
   PubMed Web of Science ®Google Scholar
• Mondoulet L, Dioszeghy V, Ligouis M, Dhelft V, Dupont C, Benhamou PH. Epicutaneous immunotherapy on intact skin using a new delivery system in a murine model of allergy. Clin Exp Allergy 2010; 40:659 - 67; http://dx.doi.org/10.1111/j.1365-2222.2009.03430.x; PMID: 20002446
   PubMed Web of Science ®Google Scholar
• Eyler JM. Smallpox in history: the birth, death, and impact of a dread disease. J Lab Clin Med 2003; 142:216 - 20; http://dx.doi.org/10.1016/S0022-2143(03)00102-1; PMID: 14625526
   PubMedGoogle Scholar
• Jodar L, Duclos P, Milstien JB, Griffiths E, Aguado MT, Clements CJ. Ensuring vaccine safety in immunization programmes--a WHO perspective. Vaccine 2001; 19:1594 - 605; http://dx.doi.org/10.1016/S0264-410X(00)00358-3; PMID: 11166881
   PubMed Web of Science ®Google Scholar
• Glenn GM, Kenney RT, Ellingsworth LR, Frech SA, Hammond SA, Zoeteweij JP. Transcutaneous immunization and immunostimulant strategies: capitalizing on the immunocompetence of the skin. Expert Rev Vaccines 2003; 2:253 - 67; http://dx.doi.org/10.1586/14760584.2.2.253; PMID: 12899576
   PubMed Web of Science ®Google Scholar
• Glenn GM, Rao M, Matyas GR, Alving CR. Skin immunization made possible by cholera toxin. Nature 1998; 391:851; http://dx.doi.org/10.1038/36014; PMID: 9495336
   PubMed Web of Science ®Google Scholar
• Glenn GM, Scharton-Kersten T, Vassell R, Mallett CP, Hale TL, Alving CR. Transcutaneous immunization with cholera toxin protects mice against lethal mucosal toxin challenge. J Immunol 1998; 161:3211 - 4; PMID: 9759833
   PubMed Web of Science ®Google Scholar
• Glenn GM, Taylor DN, Li X, Frankel S, Montemarano A, Alving CR. Transcutaneous immunization: a human vaccine delivery strategy using a patch. Nat Med 2000; 6:1403 - 6; http://dx.doi.org/10.1038/82225; PMID: 11100128
   PubMed Web of Science ®Google Scholar
• Frech SA, Kenney RT, Spyr CA, Lazar H, Viret JF, Herzog C, et al. Improved immune responses to influenza vaccination in the elderly using an immunostimulant patch. Vaccine 2005; 23:946 - 50; http://dx.doi.org/10.1016/j.vaccine.2004.06.036; PMID: 15603897
   PubMed Web of Science ®Google Scholar
• Senti G, Graf N, Haug S, Rüedi N, von Moos S, Sonderegger T, et al. Epicutaneous allergen administration as a novel method of allergen-specific immunotherapy. J Allergy Clin Immunol 2009; 124:997 - 1002; http://dx.doi.org/10.1016/j.jaci.2009.07.019; PMID: 19733905
   PubMed Web of Science ®Google Scholar
• Hurwitz SH. Medicine: Seasonal Hay Fever-Some Problems in Treatment. Cal West Med 1930; 33:520 - 1; PMID: 18741454
   PubMedGoogle Scholar
• Phillips EW. Relief of hay-fever by intradermal injections of pollen extract. JAMA 1926; 86:182 - 4; http://dx.doi.org/10.1001/jama.1926.02670290022008
   Google Scholar
• Vallery-Radot P, Hangenau J. Asthme d'origine équine. Essai de désensibilisation par des cutiréactions répétées. Bull Soc Méd Hôp Paris 1921; 45:1251 - 60
   Google Scholar
• Pautrizel R, Cabanieu G, Bricaud H, Broustet P. [Allergenic group specificity & therapeutic consequences in asthma; specific desensitization method by epicutaneous route]. Sem Hop 1957; 33:1394 - 403; PMID: 13432894
   PubMedGoogle Scholar
• Blamoutier P, Blamoutier J, Guibert L. [Treatment of pollinosis with pollen extracts by the method of cutaneous quadrille ruling]. Presse Med 1959; 67:2299 - 301; PMID: 13801278
   PubMed Web of Science ®Google Scholar
• Blamoutier P, Blamoutier J, Guibert L. Traitement co-saisonnier de la pollinose par l'application d'extraits de pollens sur des quadrillages cutanés. Revue Francaise d'Allergie 1961; 1:112 - 20; http://dx.doi.org/10.1016/S0370-4688(61)80056-2
   Google Scholar
• Eichenberger H, Storck H. Co-seasonal desensitization of pollinosis with the scarification-method of Blamoutier. Acta Allergol 1966; 21:261 - 7; PMID: 5953419
   PubMedGoogle Scholar
• Martin-DuPan R, Buser F, Neyroud M. [Treatment of pollen allergy using the cutaneous checker square method of Blamoutier and Guibert]. Schweiz Rundsch Med Prax 1971; 60:1469 - 72; PMID: 5141542
   PubMedGoogle Scholar
• Palma-Carlos A-G. Traitement co-saisonnier des pollinoses au Portugal par la méthode des quadrillages cutanés. Revue Francaise d'Allergie 1967; 7:92 - 5; http://dx.doi.org/10.1016/S0370-4688(67)80152-2
   PubMedGoogle Scholar
• Dickel H, Gambichler T, Kamphowe J, Altmeyer P, Skrygan M. Standardized tape stripping prior to patch testing induces upregulation of Hsp90, Hsp70, IL-33, TNF-alpha and IL-8/CXCL8 mRNA: new insights into the involvement of 'alarmins'. Contact Dermat 2010; 63:215 - 22; http://dx.doi.org/10.1111/j.1600-0536.2010.01769.x
   PubMed Web of Science ®Google Scholar
• Dickel H, Goulioumis A, Gambichler T, Fluhr JW, Kamphowe J, Altmeyer P, et al. Standardized tape stripping: a practical and reproducible protocol to uniformly reduce the stratum corneum. Skin Pharmacol Physiol 2010; 23:259 - 65; http://dx.doi.org/10.1159/000314700; PMID: 20484967
   PubMed Web of Science ®Google Scholar
• Dickel H, Kreft B, Kuss O, Worm M, Soost S, Brasch J, et al. Increased sensitivity of patch testing by standardized tape stripping beforehand: a multicentre diagnostic accuracy study. Contact Dermatitis 2010; 62:294 - 302; http://dx.doi.org/10.1111/j.1600-0536.2010.01710.x; PMID: 20536477
   PubMed Web of Science ®Google Scholar
• Nickoloff BJ, Naidu Y. Perturbation of epidermal barrier function correlates with initiation of cytokine cascade in human skin. J Am Acad Dermatol 1994; 30:535 - 46; http://dx.doi.org/10.1016/S0190-9622(94)70059-1; PMID: 7512582
   PubMed Web of Science ®Google Scholar
• Senti G, von Moos S, Tay F, Graf N, Sonderegger T, Johansen P, et al. Epicutaneous allergen-specific immunotherapy ameliorates grass pollen-induced rhinoconjunctivitis: A double-blind, placebo-controlled dose escalation study. J Allergy Clin Immunol 2012; 129:128 - 35; http://dx.doi.org/10.1016/j.jaci.2011.08.036; PMID: 21996342
   PubMed Web of Science ®Google Scholar
• Agostinis F, Forti S, Di Berardino F. Grass transcutaneous immunotherapy in children with seasonal rhinoconjunctivitis. Allergy 2010; 65:410 - 1; http://dx.doi.org/10.1111/j.1398-9995.2009.02189.x; PMID: 19804450
   PubMed Web of Science ®Google Scholar
• Turjanmaa K, Darsow U, Niggemann B, Rancé F, Vanto T, Werfel T. EAACI/GA2LEN position paper: present status of the atopy patch test. Allergy 2006; 61:1377 - 84; http://dx.doi.org/10.1111/j.1398-9995.2006.01136.x; PMID: 17073865
   PubMed Web of Science ®Google Scholar
• Mondoulet L, Dioszeghy V, Vanoirbeek JA, Nemery B, Dupont C, Benhamou PH. Epicutaneous immunotherapy using a new epicutaneous delivery system in mice sensitized to peanuts. Int Arch Allergy Immunol 2011; 154:299 - 309; http://dx.doi.org/10.1159/000321822; PMID: 20962535
   PubMed Web of Science ®Google Scholar
• Soury D, Barratt G, Ah-Leung S, Legrand P, Chacun H, Ponchel G. Skin localization of cow’s milk proteins delivered by a new ready-to-use atopy patch test. Pharm Res 2005; 22:1530 - 6; http://dx.doi.org/10.1007/s11095-005-5881-4; PMID: 16132366
   PubMed Web of Science ®Google Scholar
• Mondoulet L, Dioszeghy V, Ligouis M, Dhelft V, Puteaux E, Dupont C, et al. Epicutaneous immunotherapy compared with sublingual Immunotherapy in mice sensitized to pollen (Phleum pratense). ISRN Allergy 2012; 2012:e375735; http://dx.doi.org/10.5402/2012/375735
   PubMedGoogle Scholar
• Mondoulet L, Dioszeghy V, Larcher T, Ligouis M, Dhelft V, Puteaux E, et al. Epicutaneous immunotherapy (EPIT) blocks the allergic esophago-gastro-enteropathy induced by sustained oral exposure to peanuts in sensitized mice. PLoS ONE 2012; 7:e31967; http://dx.doi.org/10.1371/journal.pone.0031967; PMID: 22363776
   PubMed Web of Science ®Google Scholar
• Frey JR, Wenk P. Experimental studies on the pathogenesis of contact eczema in the guinea-pig. Int Arch Allergy Appl Immunol 1957; 11:81 - 100; http://dx.doi.org/10.1159/000228405; PMID: 13513182
   PubMedGoogle Scholar
• Kündig TM, Bachmann MF, DiPaolo C, Simard JJ, Battegay M, Lother H, et al. Fibroblasts as efficient antigen-presenting cells in lymphoid organs. Science 1995; 268:1343 - 7; http://dx.doi.org/10.1126/science.7761853; PMID: 7761853
   PubMed Web of Science ®Google Scholar
• Zinkernagel RM. Localization dose and time of antigens determine immune reactivity. Semin Immunol 2000; 12:163 - 71, discussion 257-344; http://dx.doi.org/10.1006/smim.2000.0253; PMID: 10910735
   PubMed Web of Science ®Google Scholar
• Zinkernagel RM, Ehl S, Aichele P, Oehen S, Kündig T, Hengartner H. Antigen localisation regulates immune responses in a dose- and time-dependent fashion: a geographical view of immune reactivity. Immunol Rev 1997; 156:199 - 209; http://dx.doi.org/10.1111/j.1600-065X.1997.tb00969.x; PMID: 9176709
   PubMed Web of Science ®Google Scholar
• Manolova V, Flace A, Bauer M, Schwarz K, Saudan P, Bachmann MF. Nanoparticles target distinct dendritic cell populations according to their size. Eur J Immunol 2008; 38:1404 - 13; http://dx.doi.org/10.1002/eji.200737984; PMID: 18389478
   PubMed Web of Science ®Google Scholar
• Johansen P, Mohanan D, Martínez-Gómez JM, Kündig TM, Gander B. Lympho-geographical concepts in vaccine delivery. J Control Release 2010; 148:56 - 62; http://dx.doi.org/10.1016/j.jconrel.2010.05.019; PMID: 20562028
   PubMed Web of Science ®Google Scholar
• Kündig TM, Johansen P, Senti G. Intralymphatic vaccination. In: Rapuolli R, Bagnoli F, eds. Vaccine design. Norfolk (UK): Caister Academic Press, 2011:211-24.
   Google Scholar
• Senti G, Johansen P, Kündig TM. Intralymphatic immunotherapy. Curr Opin Allergy Clin Immunol 2009; 9:537 - 43; http://dx.doi.org/10.1097/ACI.0b013e3283310ff7; PMID: 19680119
   PubMed Web of Science ®Google Scholar
• Senti G, Johansen P, Kündig TM. Intralymphatic immunotherapy: from the rationale to human applications. Curr Top Microbiol Immunol 2011; 352:71 - 84; http://dx.doi.org/10.1007/82_2011_133; PMID: 21725898
   PubMed Web of Science ®Google Scholar
• Brown K, Gao W, Alber S, Trichel A, Murphey-Corb M, Watkins SC, et al. Adenovirus-transduced dendritic cells injected into skin or lymph node prime potent simian immunodeficiency virus-specific T cell immunity in monkeys. J Immunol 2003; 171:6875 - 82; PMID: 14662894
   PubMed Web of Science ®Google Scholar
• De Vries IJ, Krooshoop DJ, Scharenborg NM, Lesterhuis WJ, Diepstra JH, Van Muijen GN, et al. Effective migration of antigen-pulsed dendritic cells to lymph nodes in melanoma patients is determined by their maturation state. Cancer Res 2003; 63:12 - 7; PMID: 12517769
   PubMed Web of Science ®Google Scholar
• de Vries IJ, Lesterhuis WJ, Barentsz JO, Verdijk P, van Krieken JH, Boerman OC, et al. Magnetic resonance tracking of dendritic cells in melanoma patients for monitoring of cellular therapy. Nat Biotechnol 2005; 23:1407 - 13; http://dx.doi.org/10.1038/nbt1154; PMID: 16258544
   PubMed Web of Science ®Google Scholar
• Bedrosian I, Mick R, Xu S, Nisenbaum H, Faries M, Zhang P, et al. Intranodal administration of peptide-pulsed mature dendritic cell vaccines results in superior CD8+ T-cell function in melanoma patients. J Clin Oncol 2003; 21:3826 - 35; http://dx.doi.org/10.1200/JCO.2003.04.042; PMID: 14551301
   PubMed Web of Science ®Google Scholar
• Lesimple T, Moisan A, Carsin A, Ollivier I, Mousseau M, Meunier B, et al. Injection by various routes of melanoma antigen-associated macrophages: biodistribution and clinical effects. Cancer Immunol Immunother 2003; 52:438 - 44; http://dx.doi.org/10.1007/s00262-003-0390-y; PMID: 12690521
   PubMed Web of Science ®Google Scholar
• Fong L, Brockstedt D, Benike C, Wu L, Engleman EG. Dendritic cells injected via different routes induce immunity in cancer patients. J Immunol 2001; 166:4254 - 9; PMID: 11238679
   PubMed Web of Science ®Google Scholar
• Ochsenbein AF, Sierro S, Odermatt B, Pericin M, Karrer U, Hermans J, et al. Roles of tumour localization, second signals and cross priming in cytotoxic T-cell induction. Nature 2001; 411:1058 - 64; http://dx.doi.org/10.1038/35082583; PMID: 11429607
   PubMed Web of Science ®Google Scholar
• Juillard GJ, Boyer PJ. Intralymphatic immunization: current status. Eur J Cancer 1977; 13:439 - 40; http://dx.doi.org/10.1016/0014-2964(77)90099-8; PMID: 872860
   PubMed Web of Science ®Google Scholar
• Juillard GJ, Boyer PJ, Niewisch H, Hom M. Distribution and consequences of cell suspensions following intralymphatic infusion. Bull Cancer 1979; 66:217 - 28; PMID: 486731
   PubMed Web of Science ®Google Scholar
• Juillard GJ, Boyer PJ, Snow HD. Intralymphatic infusion of autochthonous tumor cells in canine lymphoma. Int J Radiat Oncol Biol Phys 1976; 1:497 - 503; http://dx.doi.org/10.1016/0360-3016(76)90017-1; PMID: 972110
   PubMed Web of Science ®Google Scholar
• Juillard GJ, Boyer PJ, Yamashiro CH. A phase I study of active specific intralymphatic immunotherapy (ASILI). Cancer 1978; 41:2215 - 25; http://dx.doi.org/10.1002/1097-0142(197806)41:6<2215::AID-CNCR2820410622>3.0.CO;2-X; PMID: 77718
   PubMed Web of Science ®Google Scholar
• Juillard GJ, Boyer PJ, Yamashiro CH, Snow HD, Weisenburger TH, McCarthy T, et al. Regional intralymphatic infusion (ILI) of irradiated tumor cells with evidence of distant effects. Cancer 1977; 39:126 - 30; http://dx.doi.org/10.1002/1097-0142(197701)39:1<126::AID-CNCR2820390122>3.0.CO;2-5; PMID: 832227
   PubMed Web of Science ®Google Scholar
• Johansen P, Häffner AC, Koch F, Zepter K, Erdmann I, Maloy K, et al. Direct intralymphatic injection of peptide vaccines enhances immunogenicity. Eur J Immunol 2005; 35:568 - 74; http://dx.doi.org/10.1002/eji.200425599; PMID: 15682446
   PubMed Web of Science ®Google Scholar
• Heinzerling L, Basch V, Maloy K, Johansen P, Senti G, Wüthrich B, et al. Critical role for DNA vaccination frequency in induction of antigen-specific cytotoxic responses. Vaccine 2006; 24:1389 - 94; http://dx.doi.org/10.1016/j.vaccine.2005.09.018; PMID: 16225968
   PubMed Web of Science ®Google Scholar
• Maloy KJ, Erdmann I, Basch V, Sierro S, Kramps TA, Zinkernagel RM, et al. Intralymphatic immunization enhances DNA vaccination. Proc Natl Acad Sci USA 2001; 98:3299 - 303; http://dx.doi.org/10.1073/pnas.051630798; PMID: 11248073
   PubMed Web of Science ®Google Scholar
• Smith KA, Tam VL, Wong RM, Pagarigan RR, Meisenburg BL, Joea DK, et al. Enhancing DNA vaccination by sequential injection of lymph nodes with plasmid vectors and peptides. Vaccine 2009; 27:2603 - 15; http://dx.doi.org/10.1016/j.vaccine.2009.02.038; PMID: 19428867
   PubMed Web of Science ®Google Scholar
• Kreiter S, Diken M, Selmi A, Diekmann J, Attig S, Hüsemann Y, et al. FLT3 ligand enhances the cancer therapeutic potency of naked RNA vaccines. Cancer Res 2011; 71:6132 - 42; http://dx.doi.org/10.1158/0008-5472.CAN-11-0291; PMID: 21816907
   PubMed Web of Science ®Google Scholar
• Kreiter S, Selmi A, Diken M, Koslowski M, Britten CM, Huber C, et al. Intranodal vaccination with naked antigen-encoding RNA elicits potent prophylactic and therapeutic antitumoral immunity. Cancer Res 2010; 70:9031 - 40; http://dx.doi.org/10.1158/0008-5472.CAN-10-0699; PMID: 21045153
   PubMed Web of Science ®Google Scholar
• Van Lint S, Goyvaerts C, Maenhout S, Goethals L, Disy A, Benteyn D, et al. Preclinical evaluation of TriMix and antigen mRNA-based antitumor therapy. Cancer Res 2012; 72:1661 - 71; http://dx.doi.org/10.1158/0008-5472.CAN-11-2957; PMID: 22337996
   PubMed Web of Science ®Google Scholar
• Sigel MB, Sinha YN, VanderLaan WP. Production of antibodies by inoculation into lymph nodes. Methods Enzymol 1983; 93:3 - 12; http://dx.doi.org/10.1016/S0076-6879(83)93031-8; PMID: 6346012
   PubMed Web of Science ®Google Scholar
• Nilsson BO, Svalander PC, Larsson A. Immunization of mice and rabbits by intrasplenic deposition of nanogram quantities of protein attached to Sepharose beads or nitrocellulose paper strips. J Immunol Methods 1987; 99:67 - 75; http://dx.doi.org/10.1016/0022-1759(87)90033-0; PMID: 3571992
   PubMed Web of Science ®Google Scholar
• Lehner T, Wang Y, Cranage M, Bergmeier LA, Mitchell E, Tao L, et al. Protective mucosal immunity elicited by targeted iliac lymph node immunization with a subunit SIV envelope and core vaccine in macaques. Nat Med 1996; 2:767 - 75; http://dx.doi.org/10.1038/nm0796-767; PMID: 8673922
   PubMed Web of Science ®Google Scholar
• Bogers WM, Bergmeier LA, Ma J, Oostermeijer H, Wang Y, Kelly CG, et al. A novel HIV-CCR5 receptor vaccine strategy in the control of mucosal SIV/HIV infection. AIDS 2004; 18:25 - 36; http://dx.doi.org/10.1097/00002030-200401020-00003; PMID: 15090826
   PubMed Web of Science ®Google Scholar
• Bogers WM, Bergmeier LA, Oostermeijer H, ten Haaft P, Wang Y, Kelly CG, et al. CCR5 targeted SIV vaccination strategy preventing or inhibiting SIV infection. Vaccine 2004; 22:2974 - 84; http://dx.doi.org/10.1016/j.vaccine.2004.02.050; PMID: 15356916
   PubMed Web of Science ®Google Scholar
• Kawabata S, Miller CJ, Lehner T, Fujihashi K, Kubota M, McGhee JR, et al. Induction of Th2 cytokine expression for p27-specific IgA B cell responses after targeted lymph node immunization with simian immunodeficiency virus antigens in rhesus macaques. J Infect Dis 1998; 177:26 - 33; http://dx.doi.org/10.1086/513811; PMID: 9419166
   PubMed Web of Science ®Google Scholar
• Klavinskis LS, Bergmeier LA, Gao L, Mitchell E, Ward RG, Layton G, et al. Mucosal or targeted lymph node immunization of macaques with a particulate SIVp27 protein elicits virus-specific CTL in the genito-rectal mucosa and draining lymph nodes. J Immunol 1996; 157:2521 - 7; PMID: 8805653
   PubMed Web of Science ®Google Scholar
• Lehner T, Bergmeier LA, Tao L, Panagiotidi C, Klavinskis LS, Hussain L, et al. Targeted lymph node immunization with simian immunodeficiency virus p27 antigen to elicit genital, rectal, and urinary immune responses in nonhuman primates. J Immunol 1994; 153:1858 - 68; PMID: 7519218
   PubMed Web of Science ®Google Scholar
• Lehner T, Mitchell E, Bergmeier L, Singh M, Spallek R, Cranage M, et al. The role of gammadelta T cells in generating antiviral factors and beta-chemokines in protection against mucosal simian immunodeficiency virus infection. Eur J Immunol 2000; 30:2245 - 56; http://dx.doi.org/10.1002/1521-4141(2000)30:8<2245::AID-IMMU2245>3.0.CO;2-7; PMID: 10940916
   PubMed Web of Science ®Google Scholar
• Barth RJ Jr., Fisher DA, Wallace PK, Channon JY, Noelle RJ, Gui J, et al. A randomized trial of ex vivo CD40L activation of a dendritic cell vaccine in colorectal cancer patients: tumor-specific immune responses are associated with improved survival. Clin Cancer Res 2010; 16:5548 - 56; http://dx.doi.org/10.1158/1078-0432.CCR-10-2138; PMID: 20884622
   PubMed Web of Science ®Google Scholar
• Czerniecki BJ, Koski GK, Koldovsky U, Xu S, Cohen PA, Mick R, et al. Targeting HER-2/neu in early breast cancer development using dendritic cells with staged interleukin-12 burst secretion. Cancer Res 2007; 67:1842 - 52; http://dx.doi.org/10.1158/0008-5472.CAN-06-4038; PMID: 17293384
   PubMed Web of Science ®Google Scholar
• Fadul CE, Fisher JL, Hampton TH, Lallana EC, Li Z, Gui J, et al. Immune response in patients with newly diagnosed glioblastoma multiforme treated with intranodal autologous tumor lysate-dendritic cell vaccination after radiation chemotherapy. J Immunother 2011; 34:382 - 9; http://dx.doi.org/10.1097/CJI.0b013e318215e300; PMID: 21499132
   PubMed Web of Science ®Google Scholar
• Lesimple T, Neidhard EM, Vignard V, Lefeuvre C, Adamski H, Labarrière N, et al. Immunologic and clinical effects of injecting mature peptide-loaded dendritic cells by intralymphatic and intranodal routes in metastatic melanoma patients. Clin Cancer Res 2006; 12:7380 - 8; http://dx.doi.org/10.1158/1078-0432.CCR-06-1879; PMID: 17189411
   PubMed Web of Science ®Google Scholar
• Lesterhuis WJ, de Vries IJ, Schreibelt G, Lambeck AJ, Aarntzen EH, Jacobs JF, et al. Route of administration modulates the induction of dendritic cell vaccine-induced antigen-specific T cells in advanced melanoma patients. Clin Cancer Res 2011; 17:5725 - 35; http://dx.doi.org/10.1158/1078-0432.CCR-11-1261; PMID: 21771874
   PubMed Web of Science ®Google Scholar
• Schwaab T, Schwarzer A, Wolf B, Crocenzi TS, Seigne JD, Crosby NA, et al. Clinical and immunologic effects of intranodal autologous tumor lysate-dendritic cell vaccine with Aldesleukin (Interleukin 2) and IFN-alpha2a therapy in metastatic renal cell carcinoma patients. Clin Cancer Res 2009; 15:4986 - 92; http://dx.doi.org/10.1158/1078-0432.CCR-08-3240; PMID: 19622576
   PubMed Web of Science ®Google Scholar
• Yi Q, Szmania S, Freeman J, Qian J, Rosen NA, Viswamitra S, et al. Optimizing dendritic cell-based immunotherapy in multiple myeloma: intranodal injections of idiotype-pulsed CD40 ligand-matured vaccines led to induction of type-1 and cytotoxic T-cell immune responses in patients. Br J Haematol 2010; 150:554 - 64; http://dx.doi.org/10.1111/j.1365-2141.2010.08286.x; PMID: 20618329
   PubMed Web of Science ®Google Scholar
• Weber J, Boswell W, Smith J, Hersh E, Snively J, Diaz M, et al. Phase 1 trial of intranodal injection of a Melan-A/MART-1 DNA plasmid vaccine in patients with stage IV melanoma. J Immunother 2008; 31:215 - 23; http://dx.doi.org/10.1097/CJI.0b013e3181611420; PMID: 18481391
   PubMed Web of Science ®Google Scholar
• Ribas A, Weber JS, Chmielowski B, Comin-Anduix B, Lu D, Douek M, et al. Intra-lymph node prime-boost vaccination against Melan A and tyrosinase for the treatment of metastatic melanoma: results of a phase 1 clinical trial. Clin Cancer Res 2011; 17:2987 - 96; http://dx.doi.org/10.1158/1078-0432.CCR-10-3272; PMID: 21385924
   PubMed Web of Science ®Google Scholar
• Weber JS, Vogelzang NJ, Ernstoff MS, Goodman OB, Cranmer LD, Marshall JL, et al. A phase 1 study of a vaccine targeting preferentially expressed antigen in melanoma and prostate-specific membrane antigen in patients with advanced solid tumors. J Immunother 2011; 34:556 - 67; http://dx.doi.org/10.1097/CJI.0b013e3182280db1; PMID: 21760528
   PubMed Web of Science ®Google Scholar
• Adamina M, Rosenthal R, Weber WP, Frey DM, Viehl CT, Bolli M, et al. Intranodal immunization with a vaccinia virus encoding multiple antigenic epitopes and costimulatory molecules in metastatic melanoma. Mol Ther 2010; 18:651 - 9; http://dx.doi.org/10.1038/mt.2009.275; PMID: 19935776
   PubMed Web of Science ®Google Scholar
• Spaner DE, Astsaturov I, Vogel T, Petrella T, Elias I, Burdett-Radoux S, et al. Enhanced viral and tumor immunity with intranodal injection of canary pox viruses expressing the melanoma antigen, gp100. Cancer 2006; 106:890 - 9; http://dx.doi.org/10.1002/cncr.21669; PMID: 16404742
   PubMed Web of Science ®Google Scholar
• Arbes SJ Jr., Gergen PJ, Elliott L, Zeldin DC. Prevalences of positive skin test responses to 10 common allergens in the US population: results from the third National Health and Nutrition Examination Survey. J Allergy Clin Immunol 2005; 116:377 - 83; http://dx.doi.org/10.1016/j.jaci.2005.05.017; PMID: 16083793
   PubMed Web of Science ®Google Scholar
• The International Study of Asthma and Allergies in Childhood (ISAAC) Steering Committee. Worldwide variation in prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and atopic eczema: ISAAC. Lancet 1998; 351:1225 - 32; http://dx.doi.org/10.1016/S0140-6736(97)07302-9; PMID: 9643741
   PubMed Web of Science ®Google Scholar
• Verlato G, Corsico A, Villani S, Cerveri I, Migliore E, Accordini S, et al. Is the prevalence of adult asthma and allergic rhinitis still increasing? Results of an Italian study. J Allergy Clin Immunol 2003; 111:1232 - 8; http://dx.doi.org/10.1067/mai.2003.1484; PMID: 12789222
   PubMed Web of Science ®Google Scholar
• Wüthrich B, Schindler C, Medici TC, Zellweger JP, Leuenberger P, SAPALDIA (Swiss Study on Air Pollution and Lung Diseases in Adults) Team. IgE levels, atopy markers and hay fever in relation to age, sex and smoking status in a normal adult Swiss population. Int Arch Allergy Immunol 1996; 111:396 - 402; http://dx.doi.org/10.1159/000237398; PMID: 8957114
   PubMed Web of Science ®Google Scholar
• Pajno GB, Barberio G, De Luca F, Morabito L, Parmiani S. Prevention of new sensitizations in asthmatic children monosensitized to house dust mite by specific immunotherapy. A six-year follow-up study. Clin Exp Allergy 2001; 31:1392 - 7; http://dx.doi.org/10.1046/j.1365-2222.2001.01161.x; PMID: 11591189
   PubMed Web of Science ®Google Scholar
• Möller C, Dreborg S, Ferdousi HA, Halken S, Høst A, Jacobsen L, et al. Pollen immunotherapy reduces the development of asthma in children with seasonal rhinoconjunctivitis (the PAT-study). J Allergy Clin Immunol 2002; 109:251 - 6; http://dx.doi.org/10.1067/mai.2002.121317; PMID: 11842293
   PubMed Web of Science ®Google Scholar
• Johansen P, Senti G, Martinez Gomez JM, Storni T, von Beust BR, Wüthrich B, et al. Toll-like receptor ligands as adjuvants in allergen-specific immunotherapy. Clin Exp Allergy 2005; 35:1591 - 8; http://dx.doi.org/10.1111/j.1365-2222.2005.02384.x; PMID: 16393325
   PubMed Web of Science ®Google Scholar
• Johansen P, Senti G, Martínez Gómez JM, Wüthrich B, Bot A, Kündig TM. Heat denaturation, a simple method to improve the immunotherapeutic potential of allergens. Eur J Immunol 2005; 35:3591 - 8; http://dx.doi.org/10.1002/eji.200535076; PMID: 16285011
   PubMed Web of Science ®Google Scholar
• Martínez-Gómez JM, Johansen P, Erdmann I, Senti G, Crameri R, Kündig TM. Intralymphatic injections as a new administration route for allergen-specific immunotherapy. Int Arch Allergy Immunol 2009; 150:59 - 65; http://dx.doi.org/10.1159/000210381; PMID: 19339803
   PubMed Web of Science ®Google Scholar
• Martínez-Gómez JM, Johansen P, Rose H, Steiner M, Senti G, Rhyner C, et al. Targeting the MHC class II pathway of antigen presentation enhances immunogenicity and safety of allergen immunotherapy. Allergy 2009; 64:172 - 8; http://dx.doi.org/10.1111/j.1398-9995.2008.01812.x; PMID: 19076537
   PubMed Web of Science ®Google Scholar
• Mohanan D, Slütter B, Henriksen-Lacey M, Jiskoot W, Bouwstra JA, Perrie Y, et al. Administration routes affect the quality of immune responses: A cross-sectional evaluation of particulate antigen-delivery systems. J Control Release 2010; 147:342 - 9; http://dx.doi.org/10.1016/j.jconrel.2010.08.012; PMID: 20727926
   PubMed Web of Science ®Google Scholar
• Senti G, Prinz Vavricka BM, Erdmann I, Diaz MI, Markus R, McCormack SJ, et al. Intralymphatic allergen administration renders specific immunotherapy faster and safer: a randomized controlled trial. Proc Natl Acad Sci USA 2008; 105:17908 - 12; http://dx.doi.org/10.1073/pnas.0803725105; PMID: 19001265
   PubMed Web of Science ®Google Scholar
• Malling H, Blom L, Poulsen B, Poulsen L, Witten M. . Is intralymphatic specific immunotherapy with grass pollen allergen ready for clinical use?European Academy of Allergy and Clinical Immunology Congress. . Geneva: EAACI, 2012:S1595.
   Google Scholar
• Siegrist CA. The Immunology of Vaccination. In: Plotkin SA, Orenstein WA, Offit PA, eds. Vaccines. Philadelphia: Elsevier Inc., 2008:17-36.
   Google Scholar
• Guery JC, Galbiati F, Smiroldo S, Adorini L. Selective development of T helper (Th)2 cells induced by continuous administration of low dose soluble proteins to normal and beta(2)-microglobulin-deficient BALB/c mice. J Exp Med 1996; 183:485 - 97; http://dx.doi.org/10.1084/jem.183.2.485; PMID: 8627161
   PubMed Web of Science ®Google Scholar
• Senti G, Crameri R, Kuster D, Johansen P, Martinez-Gomez JM, Graf N, et al. Intralymphatic immunotherapy for cat allergy induces tolerance after only 3 injections. J Allergy Clin Immunol 2012; 129:1290 - 6; http://dx.doi.org/10.1016/j.jaci.2012.02.026; PMID: 22464647
   PubMed Web of Science ®Google Scholar